Home Featured Life Science Reality Check: Alexandria’s Q1 Performance Reflects Industry Challenges Despite Executive Optimism
FeaturedFinanceINDUSTRY newsLife Science

Life Science Reality Check: Alexandria’s Q1 Performance Reflects Industry Challenges Despite Executive Optimism

Share
microscope
Getty Images For Unsplash+
Share

Alexandria Real Estate Equities (ARE), a pure-play life science REIT, reported its Q1 2025 earnings on April 29th with mixed results that suggest the biotech sector continues to face significant headwinds. Despite executive chairman Joel Marcus's assertions that negative sentiment toward the industry belies reality, the company's financial performance indicates genuine challenges. The Numbers Tell […]

Thank you for your interest in The Registry. If you'd like to read further, you must Subscribe or Log In below to read the rest of this content.

Share

Partner Content

2026 Northern California CRE Rising Stars

NorCal rising stars 2026

Partner Content


Recent Posts

Related Articles

Airbnb Deals Point to 374,000 SQFT at 888 Brannan, Reversing Its Planned Retreat From 850 Brannan

Newmark's third-quarter report lists a confidential 373,903-square-foot renewal and expansion at 888...

San Francisco Readies $72MM, 300-Bed Behavioral Health Building on Treasure Island

San Francisco plans a $72 million, six-story behavioral health building on Treasure...

Gilroy Shelves Sharks Ice Rink at Sports Park After $64MM Cost Estimate Opens $15MM Funding Gap

Gilroy halts its Sharks ice rink plan after costs climbed to about...